July 24, 2007 -- WuXi PharmaTech is planning a $200 million IPO on a US exchange, according to an article on Bloomberg, saying the company would complete its filing with the SEC this week. Shanghai-based WuXi has been extremely successful. Founded in 2001 by “returnee” Dr. Ge Li, the company has grown in just six years into an operation that employs more than 1500 scientists. With more growth expected in the future, WuXi is at the top of its game, a perfect time for an IPO. More details...
